Authors


Center for Heart Failure Research, University of Alabama at Birmingha

Latest:

Chronic diuretic use and increased mortality and hospitalization in heart failure

Diuretic use is associated with activation of neurohormones and disease progression in heart failure. Yet, diuretics are commonly prescribed, although little is known about their long-term effects. We performed a study based on propensity score matching, which indicated that in subjects with ambulatory, chronic, mild-to-moderate heart failure, diuretic use was associated with increased mortality and hospitalization. These findings call into question the wisdom of using long-term diuretic therapy in heart failure patients who are asymptomatic or minimally symptomatic.





Harold L. Lazar, MD is professor of cardiothoracic surgery, Boston University School of Medicine, Boston, Massachusetts.

Latest:

Creatine kinase-MB elevation following coronary artery bypass graft surgery: What is its significance and should it be measured in all patients?

In their study consisting of coronary artery bypass graft (CABG) patients recruited from 4 major trials, Mahaffey found that creatine kinase-myocardial band (CK-MB) elevations following CABG surgery are independently associated with an increased risk of mortality in patients with non–ST-segment elevation acute coronary syndromes, especially if the peak CK-MB level is > 5 x the upper limit of normal (ULN).


Caitlyn Fitzpatrick

Latest:

HIV in Prison: How Inmates and Partners Are at Risk

Prisons are breeding grounds for STIs, including HIV. What can fix that?


Tony Yen, MD

Latest:

The EMR as a Catalyst for Quality

The EMR has long promised a brave new world in which clinical information is synthesized, individualized, and seamlessly delivered to the frontline clinician.




Dr. Enoch Choi

Latest:

The Logistics of Getting to Haiti

Identifying the needs of the Haitians who were affected by the earthquake, finding a place to stay and work, and getting there would be impossible for us without the help and coordinated efforts of many people.


Germano Di Sciascio, MD: From the Department of Cardiovascular Sciences, Campus Bio-Medico University, Rome, Italy.

Latest:

Atorvastatin pretreatment in early percutaneous coronary intervention

According to results of the Atorvastatin for Reduction of Myocardial Damage During Angioplasty-Acute Coronary Syndromes (ARMYDA-ACS) trial, short-term pretreatment with high-dose atorvastatin prior to percutaneous coronary intervention improves clinical outcome in subjects with unstable angina and non-ST-segment elevation myocardial infarction. These findings support the upstream administration of high-dose statins in subjects with acute coronary syndrome treated with an early invasive strategy.


David Friedman, MD, FACC, FACP

Latest:

Are Hillary Clinton and Donald Trump Healthy Enough to be President?

Will our next president be medically fit? And how much is the public entitled to know about candidates’ personal health?



Joe Hannan

Latest:

FDA Approves Adamis' Cheaper Alternative to EpiPen

Adamis developed a single-dose epinephrine pre-filled syringe to treat anaphylaxis.






Lexa W. Lee

Latest:

Updates in Surgery: Percutaneous Coronary Intervention, Perioperative Biomarkers, and Troponin

During a follow-on session at the 2013 Southern Hospital Medicine Conference, Steven Cohn, MD, discussed the effect of PCI on subsequent non-cardiac surgery outcomes, monitoring specific hormone levels as indicators of cardiovascular risk, and other hot topics in perioperative medicine.


Anita Deswal, MD, MPH

Latest:

Outcomes in women vs men with heart failure and preserved ejection fraction

The epidemiologic finding that women with heart failure have better overall survival than men may be because of the higher prevalence of diastolic heart failure or heart failure with preserved ejection fraction (HF-PEF) among women.




Antoni Ribas, MD

Latest:

Melanoma: Improving Clinical Outcomes Through Advances in Immunotherapeutics and Targeted Therapy

Metastatic melanoma has limited treatment options, but advances in the understanding of the oncogenic mutations that drive this cancer and how the immune system can be better modulated to fight melanoma provide a new generation of active approaches for patients.



associate professor of medicine, Division of Cardiology, Johns Hopkins Hospital, Baltimore, Maryland, an

Latest:

Thoracic and abdominal aorticatherosclerosis

It was not until Virchow identified the cellular contributions to thrombosis that physicians began to visualize arteries as dynamic tissues.



Todd Kislak

Latest:

A Tour of Hospital Medicine in the Blogosphere

With the ranks of hospitalists already over 20,000 strong and growing every day, hospital medicine is the fastest-growing medical specialty in the history of American healthcare


epidemiology, Division of Cardiology, The Johns Hopkins University, Baltimore, Maryland.

Latest:

Uncovering masked hypertension: Is the blood pressure really normal?

A number of studies have documented the incremental predictive ability of 24 hour ambulatory blood pressure (BP) monitoring over traditional office or casual BP monitoring for predicting adverse cardiovascular events.


Brian Bigger, Ph.D.

Latest:

A Sense of Urgency in Sanfilippo Therapy Development

With no real standard-of-care for Sanfilippo syndrome patients, Brian Bigger, Ph.D., discusses the sense of urgency he and his colleagues feel while researching.


© 2024 MJH Life Sciences

All rights reserved.